| 标题 |
Camizestrant, a next-generation oral SERD, versus fulvestrant in post-menopausal women with oestrogen receptor-positive, HER2-negative advanced breast cancer (SERENA-2): a multi-dose, open-label, randomised, phase 2 trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:Lancet Oncology 作者:Mafalda Oliveira; Denys Pominchuk; Zbigniew Nowecki; Erika Hamilton; Yaroslav Kulyaba; et al 出版日期:2024-10-29 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)